Quantitative 3D T1ρ imaging shows a significant decrease in cervical cancer tumor values, suggesting its potential in monitoring response during chemoradiation.
Key Points
Significant decreases in T1ρ values were observed by week 2, indicating early treatment response.
At week 3, an 18.81% reduction in tumor T1ρ values was recorded, highlighting treatment effectiveness.
3D T1ρ imaging was conducted on four cervical cancer patients during a five-week treatment period.
The findings suggest that T1ρ imaging can help personalize treatment plans based on early assessment.